Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CXA-10 in Stage 3 and 4 Chronic Kidney Injury
NCT02248051Phase 1Completed
- Sponsor
- Complexa Therapeutics
- Start
- Sep 2014
- Primary completion
- Aug 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of 10-nitro-oleic acid in chronic kidney disease (CKD) (2 arms), sponsored by Complexa Therapeutics. Primary endpoint: Number of subjects with Serious and Non-Serious Adverse Events at 30 days. Started Sep 2014; status: completed.
02
Drugs
10-nitro-oleic acid
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on NCT02248051.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02248051.